Latest News about BNTX
Recent news which mentions BNTX
3 Biotech Stocks That Soared in 2021 and Could Go Even Higher in 2022
December 19, 2021
From Motley Fool
Can Omicron Variant Antibodies Protect From Other Covid-19 Variants?
December 18, 2021
From Motley Fool
Is This New Data on Valneva's Less-Effective Booster Concerning?
December 18, 2021
From Motley Fool
Why Pfizer and Johnson & Johnson Fell on Friday
December 17, 2021
From Motley Fool
Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 Years
December 17, 2021
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
December 17, 2021
From Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
From Benzinga
Why Moderna and Pfizer Beat the Market Today
December 16, 2021
From Motley Fool
Why Novavax, BioNTech, and Moderna Stocks Are Jumping This Week
December 16, 2021
From Motley Fool
Why Arcturus Therapeutics Stock Was Up 16% Thursday
December 16, 2021
From Motley Fool
From Benzinga
3 Stocks That Just Declared Dividend Raises
December 16, 2021
From Motley Fool
While Novavax Stock Remains Cursed, It Might Be Time to Buy
December 16, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021
December 16, 2021
From Benzinga
Drug makers move forward with new COVID-19 booster candidates amid omicron’s spread and mass booster campaigns
December 15, 2021
From MarketWatch
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Omicron variant remains a ‘very high’ risk as it spreads fast and shows resistance to vaccines, but WHO says more data needed to know if it’s more lethal
December 15, 2021
From MarketWatch
From MarketWatch
South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine Protection
December 14, 2021
From Benzinga
Pfizer’s COVID-19 antiviral proves almost 90% effective in latest trial data, as U.S. passes 50 million confirmed cases of the illness
December 14, 2021
From MarketWatch
This major bank expects meme-stock madness and 99th percentile valuations to continue. Here’s why.
December 14, 2021
From MarketWatch
Pfizer stock heads toward record after $6.7 billion takeover of Arena; deal ‘makes strategic sense to us,’ says analyst
December 13, 2021
From MarketWatch
How Much Will COVID Boosters for Teens Impact Pfizer and BioNTech?
December 13, 2021
From Motley Fool
UK Reports First Omicron Death, PM Johnson Encourages Boosters
December 13, 2021
From Benzinga
Why BioNTech, Moderna, and Novavax Stocks Are Jumping Today
December 13, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.